News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			After market 06:14:54 pm
131.2 ^USD	+0.37%		130.5	-0.53%

Apr. 26	Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	MT
Apr. 26	Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	Apr. 26	MT
Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	Apr. 26	MT
Guggenheim Adjusts Price Target on Merck to $146 From $144	Apr. 26	MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	Apr. 26	MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135	Apr. 26	MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140	Apr. 26	MT
Goldman Sachs Raises Price Target on Merck & Company to $144 From $139	Apr. 26	MT
Leerink Partners Raises Price Target on Merck & Company to $136 From $132	Apr. 26	MT
Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating	Apr. 26	MT
AbbVie raises annual profit forecast on strong Skyrizi sales	Apr. 26	RE
Jefferies Adjusts Merck & Company Price Target to $150 From $145	Apr. 26	MT
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating	Apr. 25	MT
Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	Apr. 25	MT
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	Apr. 25
The specter of stagflation rears its ugly head again	Apr. 25
Transcript : Merck & Co., Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Merck Lifts Full-Year 2024 Outlook Following First-Quarter Beat	Apr. 25	MT
Merck raises annual target ranges	Apr. 25	CF
Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised	Apr. 25	MT
(MRK) MERCK & CO. Expects Fiscal Year 2024 EPS Range $8.53 - $8.65	Apr. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Summary

Filters